Nicholas C. Nicolaides

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Block‑Removed Immunoglobulin Technology to enhance rituximab effector function by counteracting CA125‑mediated immunosuppression”.

Block‑Removed Immunoglobulin Technology to enhance rituximab effector function by counteracting CA125‑mediated immunosuppression

Oncology Letters(2021)10.3892/ol.2021.13120

N/A

0DataRank · unranked

4 citations

J. Bradford Kline, Nicholas C. Nicolaides, Luigi Grasso

NAV‐003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors

European Journal of Immunology(2023)10.1002/eji.202250309

N/A

0DataRank · unranked

5 citations

Qun Jiang, Raffit Hassan, Nicholas C. Nicolaides, J. Bradford Kline, Luigi Grasso